ENDRA Life Sciences (NDRA) Shares Outstanding (Weighted Average) (2016 - 2021)
Historic Shares Outstanding (Weighted Average) for ENDRA Life Sciences (NDRA) over the last 6 years, with Q3 2021 value amounting to $41.9 million.
- ENDRA Life Sciences' Shares Outstanding (Weighted Average) rose 7544.27% to $41.9 million in Q3 2021 from the same period last year, while for Sep 2021 it was $41.9 million, marking a year-over-year increase of 7544.27%. This contributed to the annual value of $19.2 million for FY2020, which is 15589.69% up from last year.
- Per ENDRA Life Sciences' latest filing, its Shares Outstanding (Weighted Average) stood at $41.9 million for Q3 2021, which was up 7544.27% from $41.7 million recorded in Q2 2021.
- Over the past 5 years, ENDRA Life Sciences' Shares Outstanding (Weighted Average) peaked at $41.9 million during Q3 2021, and registered a low of $723335.0 during Q1 2017.
- Its 5-year average for Shares Outstanding (Weighted Average) is $13.0 million, with a median of $7.4 million in 2019.
- In the last 5 years, ENDRA Life Sciences' Shares Outstanding (Weighted Average) changed by 0.0% in 2017 and then surged by 44235.27% in 2018.
- Quarter analysis of 5 years shows ENDRA Life Sciences' Shares Outstanding (Weighted Average) stood at $2.8 million in 2017, then skyrocketed by 63.4% to $4.5 million in 2018, then surged by 66.49% to $7.5 million in 2019, then skyrocketed by 155.9% to $19.2 million in 2020, then soared by 118.38% to $41.9 million in 2021.
- Its Shares Outstanding (Weighted Average) was $41.9 million in Q3 2021, compared to $41.7 million in Q2 2021 and $37.8 million in Q1 2021.